Is HIV-1 induction of macrophage expression of PD-L1 and PD-L2 its weakest or strongest link to disease? HIV-1 plays both sides by augmenting and limiting T cell activation to survive in vivo

Journal of Leukocyte Biology

Volumn 89, Issue 4, 2011, Pages 495-498

  Patro, Sean C ^a   Montaner, Luis J ^a  

^a WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN; PROTEIN PD L1; PROTEIN PD L2; UNCLASSIFIED DRUG; B7 ANTIGEN; B7 DC ANTIGEN; B7-DC ANTIGEN; CD274 PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IMMUNOPATHOGENESIS; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE ACTIVATION; VIRUS PATHOGENESIS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METABOLISM;

HUMAN IMMUNODEFICIENCY VIRUS 1;

ANTIGENS, CD; ANTIGENS, CD80; HIV INFECTIONS; HIV-1; HUMANS; LYMPHOCYTE ACTIVATION; MACROPHAGES;

EID: 79953712597     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.1110625     Document Type: Editorial

References (12)

1. Rodríguez-García, M., Porichis, F., de Jong, O. G., Levi, K., Dienfenbach, T. J., Lifson, J. D., Freeman, G. J., Walker, B. D., Kaufmann, D. E., Kavanagh, D. G. (2011) Expression of PD-L1 and PD-L2 on human macrophages is up-regulated by HIV-1 and differentially modulated by IL-10. J. Leukoc. Biol. 89, 507-515.
2. Phillips, R. E., Rowland-Jones, S., Nixon, D. F., Gotch, F. M., Edwards, J. P., Ogunlesi, A. O., Elvin, J. G., Rothbard, J. A., Bangham, C. R., Rizza, C. R., McMichael, A. J. (1991) Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition. Nature 354, 453-459.
3. Rouse, B. T., Sehrawat, S. (2010) Immunity and immunopathology to viruses: what decides the outcome? Nat. Rev. Immunol. 10, 514-526.
4. Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M. R., Delwart, E., Sepulveda, H., Balderas, R. S., Routy, J., Haddad, E. K., Sekaly, R. (2006) Upregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction. Nat. Med. 12, 1198-1202.
5. + T cell survival in HIV infection. J. Exp. Med. 203, 2281-2292.
6. Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., De-Pierres, C., Mncube, Z., Duraiswamy, J., Zhu, B., Eichbaum, Q., Altfeld, M., Wherry, E. J., Coovadia, H. M., Goulder, P. J. R., Klenerman, P., Ahmed, R., Freeman. G. J., Walker, B. D. (2006) PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature 443, 350-354.
7. + T cell activation during HIV infection. Nat. Med. 16, 452-459.
8. Velu, V., Titanji, K., Zhu, B., Husain, S., Pladevega, A., Lai, L., Vanderford, T. H., Chennareddi, L., Silvestri, G., Freeman, G. J., Ahmed, R., Amara, R. R. (2009) Enhancing SIV-specific immunity in vivo by PD-1 blockade. Nature 458, 206-210.
9. Boasso, A., Hardy, A. W., Landay, A. L., Martinson, J. L., Anderson, S. A., Dolan, M. J., Clerici, M., Shearer, G. M. (2008) PDL-1 upregulation on monocytes and T cells by HIV via type I interferon: restricted expression of type I interferon receptor by CCR5-expressing leukocytes. Clin. Immunol. 129, 132-144.
10. Sharpe, A. H., Wherry, E. J., Ahmed, R., Freeman, G. J. (2007) The function of programmed cell death 1 and its ligands in regulating autoimmunity and infection. Nat. Immunol. 8, 239-245.
11. Latchman, Y. E., Liang, S. C., Wu, Y., Chernova, T., Sobel, R. A., Klemm, M., Kuchroo, V. J., Freeman, G. J., Sharpe, A. H. (2004) PD-L1-deficient mice show that PD-L1 on T cells, antigen-presenting cells, and host tissues negatively regulates T cells. Proc. Natl. Acad. Sci. USA 101, 10691-10696.
12. Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., Gilbert, P. B., Lama, J. R., Marmor, M., del Rio, C., McElrath, M. J., Casimiro, D. R., Gottesdiener, K. M., Chodakewitz, J. A., Corey, L., Robertson, M. N., Step Study Protocol Team (2008) Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomized, placebo-controlled, test-of-concept trial. Lancet 372, 1881-1893.